Skip to content
Lower risk Drug recall · FDA · Published March 7, 2017

Legacy Pharmaceutical ATENOLOL Tablets May Contain Foreign Paroxetine Tablets

Legacy Pharmaceutical Packaging LLC recalls 50mg atenolol tablets due to customer reports of paroxetine tablets in some bottles. This could cause unintended medication interactions.

🇺🇸 FDA recall #D-0606-2017DrugLegacy Pharmaceutical Packaging LLC ›
Take action

Contact the company

Recalling firmLegacy Pharmaceutical Packaging LLC13333 Lakefront Dr · Earth City, MO 63045-1514
✎ GovInfoNow plain-language explainer

What happened, in plain English

Legacy Pharmaceutical Packaging LLC is recalling 50mg atenolol tablets because some bottles contain foreign paroxetine tablets. This could lead to unintended medication interactions if taken together. Read more at govinfonow.com/recall/41852-legacy-pharmaceutical-atenolol-tablets-may-contain-foreign-paroxetine-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/41852-legacy-pharmaceutical-atenolol-tablets-may-contain-foreign-paroxetine-tablets · Updated October 8, 2026 · FDA enforcement record: FDA #D-0606-2017

Cite this page

“Legacy Pharmaceutical ATENOLOL Tablets May Contain Foreign Paroxetine Tablets.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41852-legacy-pharmaceutical-atenolol-tablets-may-contain-foreign-paroxetine-tablets. Based on FDA recall #D-0606-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0606-2017%22&limit=1).

Why it’s dangerous

The recall is for customer reports that some bottles of atenolol tablets contain paroxetine tablets. Taking both medications together could cause unintended interactions since they are different prescription drugs.

Who’s affected

People who have the 50mg atenolol tablets from Legacy Pharmaceutical Packaging LLC. Those taking atenolol for heart conditions are most at risk if they accidentally take the foreign paroxetine tablets.

How to tell if you have this one

Check for the 50mg atenolol tablets with NDC 68645-493-54. The product was distributed by The Kroger Co. in Cincinnati, Ohio, and manufactured for Zydus Pharmaceuticals USA Inc.

  • Brand
    Legacy Pharmaceutical Packaging LLC
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Look for the 50mg atenolol tablets with NDC 68645-493-54. The product was distributed by The Kroger Co. in Cincinnati, Ohio.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 3 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “Product was shipped to distribution centers in TN, IN, and AZ then further shipped the product to retail pharmacies nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, Indiana, Tennessee.

Recall timeline

FDA terminated this recall 2.5 years after the firm started it.

1. Firm started the recall: Mar 7, 201712. FDA classified it Class II: Mar 21, 201723. Published in FDA’s Enforcement Report: Mar 29, 201734. FDA terminated the recall: Aug 23, 2019420172019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have this medication?

Check if you have the 50mg atenolol tablets with NDC 68645-493-54. If you do, contact your doctor or pharmacist for advice.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0606-2017 (March 7, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0606-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA